{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T06:01:05Z","timestamp":1785477665891,"version":"3.56.0"},"reference-count":33,"publisher":"XMLink","issue":"3","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["dnd.or.kr"],"crossmark-restriction":false},"short-container-title":["Dement Neurocogn Disord"],"published-print":{"date-parts":[[2026]]},"DOI":"10.12779\/dnd.2026.25.3.152","type":"journal-article","created":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T05:39:38Z","timestamp":1785476378000},"page":"152","update-policy":"https:\/\/doi.org\/10.12779\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Druggable Pathophysiologic Targets in Alzheimer Disease: From Amyloid and Tau to Biomarker-Guided Multimodal Therapy"],"prefix":"10.12779","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-2158-5924","authenticated-orcid":false,"given":"Jiwon","family":"Park","sequence":"first","affiliation":[{"name":"College of Pharmacy and Institute for Drug Research, Yeungnam University, Gyeongsan, Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"18617","reference":[{"key":"10.12779\/dnd.2026.25.3.152_ref1","unstructured":"World Health Organization. Dementia [Internet]. Geneva. World Health Organization. 2025. cited 2026 May 5. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/dementia"},{"key":"10.12779\/dnd.2026.25.3.152_ref2","doi-asserted-by":"crossref","first-page":"e70235","DOI":"10.1002\/alz.70235","volume":"21","author":"Alzheimer\u2019s Association","year":"2025","journal-title":"Alzheimers Dement (N Y)"},{"key":"10.12779\/dnd.2026.25.3.152_ref3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"van Dyck","year":"2023","journal-title":"N Engl J Med"},{"key":"10.12779\/dnd.2026.25.3.152_ref4","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1001\/jama.2023.13239","volume":"330","author":"Sims","year":"2023","journal-title":"JAMA"},{"key":"10.12779\/dnd.2026.25.3.152_ref5","doi-asserted-by":"crossref","first-page":"165","DOI":"10.12779\/dnd.2024.23.4.165","volume":"23","author":"Park","year":"2024","journal-title":"Dement Neurocogn Disord"},{"key":"10.12779\/dnd.2026.25.3.152_ref6","doi-asserted-by":"crossref","first-page":"e70098","DOI":"10.1002\/trc2.70098","volume":"11","author":"Cummings","year":"2025","journal-title":"Alzheimers Dement (N Y)"},{"key":"10.12779\/dnd.2026.25.3.152_ref7","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0140-6736(24)01296-0","volume":"404","author":"Livingston","year":"2024","journal-title":"Lancet"},{"key":"10.12779\/dnd.2026.25.3.152_ref8","doi-asserted-by":"crossref","first-page":"5143","DOI":"10.1002\/alz.13859","volume":"20","author":"Jack","year":"2024","journal-title":"Alzheimers Dement"},{"key":"10.12779\/dnd.2026.25.3.152_ref9","unstructured":"U.S. Food and Drug Administration. FDA approves treatment for adults with Alzheimer\u2019s disease [Internet]. Silver Spring. U.S. Food and Drug Administration. 2024. cited 2026 May 5. Available from: https:\/\/www.fda.gov\/drugs\/news-events-human-drugs\/fda-approves-treatment-adults-alzheimers-disease"},{"key":"10.12779\/dnd.2026.25.3.152_ref10","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","volume":"397","author":"Scheltens","year":"2021","journal-title":"Lancet"},{"key":"10.12779\/dnd.2026.25.3.152_ref11","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1001\/jamaneurol.2023.5319","volume":"81","author":"Ashton","year":"2024","journal-title":"JAMA Neurol"},{"key":"10.12779\/dnd.2026.25.3.152_ref12","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1038\/s41591-024-02869-z","volume":"30","author":"Barth\u00e9lemy","year":"2024","journal-title":"Nat Med"},{"key":"10.12779\/dnd.2026.25.3.152_ref13","unstructured":"U.S. Food and Drug Administration. FDA clears first blood test used in diagnosing Alzheimer\u2019s disease [Internet]. Silver Spring. U.S. Food and Drug Administration. 2025. cited 2026 May 5. Available from: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-clears-first-blood-test-used-diagnosing-alzheimers-disease"},{"key":"10.12779\/dnd.2026.25.3.152_ref14","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/s41591-021-01382-x","volume":"27","author":"Hansson","year":"2021","journal-title":"Nat Med"},{"key":"10.12779\/dnd.2026.25.3.152_ref15","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/s43587-022-00269-x","volume":"2","author":"Hampel","year":"2022","journal-title":"Nat Aging"},{"key":"10.12779\/dnd.2026.25.3.152_ref16","unstructured":"Biogen. Biogen to realign resources for Alzheimer\u2019s disease franchise [Internet]. Cambridge. Biogen. 2024. cited 2026 May 5. Available from: https:\/\/investors.biogen.com\/news-releases\/news-release-details\/biogen-realign-resources-alzheimers-disease-franchise"},{"key":"10.12779\/dnd.2026.25.3.152_ref17","unstructured":"U.S. Food and Drug Administration. FDA converts novel Alzheimer\u2019s disease treatment to traditional approval [Internet]. Silver Spring. U.S. Food and Drug Administration. 2023. cited 2026 May 5. Available from: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-converts-novel-alzheimers-disease-treatment-traditional-approval"},{"key":"10.12779\/dnd.2026.25.3.152_ref18","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41582-019-0281-2","volume":"16","author":"Greenberg","year":"2020","journal-title":"Nat Rev Neurol"},{"key":"10.12779\/dnd.2026.25.3.152_ref19","doi-asserted-by":"crossref","first-page":"362","DOI":"10.14283\/jpad.2023.30","volume":"10","author":"Cummings","year":"2023","journal-title":"J Prev Alzheimers Dis"},{"key":"10.12779\/dnd.2026.25.3.152_ref20","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/nrd3505","volume":"10","author":"Karran","year":"2011","journal-title":"Nat Rev Drug Discov"},{"key":"10.12779\/dnd.2026.25.3.152_ref21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jalz.2011.10.007","volume":"8","author":"Hyman","year":"2012","journal-title":"Alzheimers Dement"},{"key":"10.12779\/dnd.2026.25.3.152_ref22","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol"},{"key":"10.12779\/dnd.2026.25.3.152_ref23","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.cell.2019.09.001","volume":"179","author":"Long","year":"2019","journal-title":"Cell"},{"key":"10.12779\/dnd.2026.25.3.152_ref24","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41582-020-00435-y","volume":"17","author":"Leng","year":"2021","journal-title":"Nat Rev Neurol"},{"key":"10.12779\/dnd.2026.25.3.152_ref25","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1083\/jcb.201709069","volume":"217","author":"Hansen","year":"2018","journal-title":"J Cell Biol"},{"key":"10.12779\/dnd.2026.25.3.152_ref26","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","volume":"14","author":"Heneka","year":"2015","journal-title":"Lancet Neurol"},{"key":"10.12779\/dnd.2026.25.3.152_ref27","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","volume":"14","author":"Sweeney","year":"2018","journal-title":"Nat Rev Neurol"},{"key":"10.12779\/dnd.2026.25.3.152_ref28","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41586-020-2247-3","volume":"581","author":"Montagne","year":"2020","journal-title":"Nature"},{"key":"10.12779\/dnd.2026.25.3.152_ref29","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/s41583-019-0132-6","volume":"20","author":"Butterfield","year":"2019","journal-title":"Nat Rev Neurosci"},{"key":"10.12779\/dnd.2026.25.3.152_ref30","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/s41573-020-0072-x","volume":"19","author":"Cunnane","year":"2020","journal-title":"Nat Rev Drug Discov"},{"key":"10.12779\/dnd.2026.25.3.152_ref31","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.cell.2015.12.056","volume":"164","author":"De Strooper","year":"2016","journal-title":"Cell"},{"key":"10.12779\/dnd.2026.25.3.152_ref32","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1001\/jama.2019.2000","volume":"321","author":"Rabinovici","year":"2019","journal-title":"JAMA"},{"key":"10.12779\/dnd.2026.25.3.152_ref33","unstructured":"Roche. Roche presents new insights in Alzheimer\u2019s disease research across its diagnostics and pharmaceutical portfolios at AAIC [Internet]. Basel. Roche. 2025. cited 2026 Jun 25. Available from: https:\/\/www.roche.com\/media\/releases\/med-cor-2025-07-28"}],"container-title":["Dementia and Neurocognitive Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dnd.or.kr\/pdf\/10.12779\/dnd.2026.25.3.152","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/dnd.or.kr\/DOIx.php?id=10.12779\/dnd.2026.25.3.152","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/dnd.or.kr\/DOIx.php?id=10.12779\/dnd.2026.25.3.152","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T05:40:59Z","timestamp":1785476459000},"score":1,"resource":{"primary":{"URL":"https:\/\/dnd.or.kr\/DOIx.php?id=10.12779\/dnd.2026.25.3.152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.12779\/dnd.2026.25.3.152","relation":{},"ISSN":["1738-1495","2384-0757"],"issn-type":[{"value":"1738-1495","type":"print"},{"value":"2384-0757","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"2026-05-05","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-05","name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-06","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-16","name":"published_online","label":"Published online","group":{"name":"publication_history","label":"Publication History"}},{"value":"\u00a9 2026 The Author(s). Published by the Korean Dementia Association.","name":"copyright","label":"Copyright","group":{"name":"Copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.","name":"license","label":"License","explanation":{"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},"group":{"name":"Copyright_and_licensing","label":"Copyright and Licensing"}}]}}